Teva Pharmaceutical Industries LimitedTEVANYSE
Loading
Free Cash Flow Growth AcceleratingAccelerating
Percentile Rank86
3Y CAGR-46.2%
5Y CAGR+0.4%
Year-over-Year Change
Year-over-year free cash flow growth rate
3Y CAGR
-46.2%/yr
Annual compound
5Y CAGR
+0.4%/yr
Recent deceleration
Percentile
P86
Within normal range
vs 5Y Ago
1x
Modest growth
Streak
2 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2025 | 53.27% |
| 2024 | -11.05% |
| 2023 | -19.19% |
| 2022 | 341.53% |
| 2021 | -63.01% |
| 2020 | 52.27% |
| 2019 | -76.66% |
| 2018 | -31.83% |
| 2017 | -39.11% |
| 2016 | -9.35% |